EUVIMEDEUVIMED entdecken
Crossref

Intravesically administered human defensin-5 ameliorates E. coli induced catheter associated-urinary tract infections in female SD rats

Shamli, Mandip Singh Bhatia, Praveen Rishi, Simran Preet

Archives of Microbiology · 2026-11 · 208 (11)

DOI: 10.1007/s00203-026-04967-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Microbiology, online erschienen am 17.08.2026. Verfasst von Shamli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics, Har Gobind Khorana Block, South campus, Panjab University, Sector-25, Chandigarh, 160014, India. Hauptthemen laut MEDLINE: Urinary Tract Infections, Escherichia coli Infections, Uropathogenic Escherichia coli, Catheter-Related Infections. Die Arbeit nennt 64 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The existing treatment approaches against urinary tract infections (UTIs) are associated with severe side effects and antimicrobial resistance. Human defensin-5 (HD-5) is an important component of the innate defense mechanism in the urinary tract. The aim of our study was to evaluate the antimicrobial potential of intravesically administered HD-5 against uropathogenic Escherichia coli (UPEC) in rat cystitis model. To the best of our knowledge, this is the first study to demonstrate the therapeutic role of exogenously administered HD-5, in UTIs. With an MIC of 60 µg/ml against UPEC, HD-5 exerted antimicrobial activity primarily by disrupting membrane integrity, leading to blebbing, release of extracellular contents, and ultimately whole-cell lysis. HD-5 administered via the intravesical route significantly reduced UPEC load by 54% in bladder and 50% in urine. H and E staining of treated bladders indicated reduced inflammation and improved architectural integrity establishing a strong anti-inflammatory potential of HD-5. Also, there was visible improvement in blood parameters like TLC, DLC, Platelets and Haemoglobin in treated animals suggesting its possible immunomodulatory role. The relative efficacy of the tested therapeutic agents was found to be in the order of intravesical HD-5 > oral ciprofloxacin > intravesical ciprofloxacin > oral HD-5 under the present experimental conditions. Interestingly, intravesical dosing of HD-5 was found to be overall effective in the present UTI model, likely due to direct targeting at the site of infection. Our findings establish HD-5 as a potent anti-UPEC agent which can be developed as an alternate strategy to combat hospital-acquired catheter associated UTIs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Tract InfectionsEscherichia coli InfectionsUropathogenic Escherichia coliCatheter-Related Infectionsalpha-DefensinsAnti-Bacterial AgentsAnimalsFemaleRats, Sprague-DawleyRatsHumansAdministration, IntravesicalUrinary BladderCystitisDisease Models, AnimalMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Anti-microbial peptidesHuman defensin-5Intravesical therapyOral deliveryUrinary tract infectionsUropathogenic E. coli

Substanzen

alpha-DefensinsDEFA5 protein, humanAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Biophysics, Har Gobind Khorana Block, South campus, Panjab University, Sector-25, Chandigarh, 160014, India.
  • Department of Internal Medicine, Post-Graduate Institute of Medical Research and Education, PGIMER, Sector-12, Chandigarh, 160012, India.
  • Department of Microbiology, Venky Ramakrishnan Block, South campus, Panjab University, Sector-25, Chandigarh, 160014, India.
  • Department of Biophysics, Har Gobind Khorana Block, South campus, Panjab University, Sector-25, Chandigarh, 160014, India. simranpreet@pu.ac.in.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Shamli, Bhatia, M. S., Rishi, P., & Preet, S. (2026). Intravesically administered human defensin-5 ameliorates E. coli induced catheter associated-urinary tract infections in female SD rats. Archives of Microbiology, 208(11). https://doi.org/10.1007/s00203-026-04967-7

Vancouver

Shamli, Bhatia MS, Rishi P, Preet S. Intravesically administered human defensin-5 ameliorates E. coli induced catheter associated-urinary tract infections in female SD rats. Archives of Microbiology. 2026;208(11). doi:10.1007/s00203-026-04967-7

BibTeX
@article{Shamli2026,
  author = {Shamli and Bhatia, Mandip Singh and Rishi, Praveen and Preet, Simran},
  title = {Intravesically administered human defensin-5 ameliorates E. coli induced catheter associated-urinary tract infections in female SD rats},
  journal = {Archives of Microbiology},
  year = {2026},
  volume = {208},
  number = {11},
  doi = {10.1007/s00203-026-04967-7}
}
Kostenlos starten →